|Title:||Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid and their use as antiviral agents|
|Abstract:||Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid, pharmaceutical formulations thereof, methods for their preparation .and their use in the treatment of viral infections, in particular influenza, are described.|
|Inventor(s):||von Izstein; Laurence M. (North Fitzray, AU), Wu; Wen-Yang (Mount Waverley, AU), Phan; Tho V. (Carnegie, AU), Danylec; Basil (Box Hill, AU), Jin; Betty (Mount Waverley, AU)|
|Assignee:||Biota Scientific Management Pty Ltd (Melbourne, AU)|
Patent Claim Types:|
see list of patent claims
|Compound; Composition; Formulation;|
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|Australia||PJ9800||Apr 24, 1990|
|Australia||PK2896||Oct 19, 1990|
|Australia||PK4537||Feb 11, 1991|
|PCT Filed||April 24, 1991||PCT Application Number:||PCT/AU91/00161|
|PCT Publication Date:||October 31, 1991||PCT Publication Number:||WO91/16320|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|African Regional IP Organization (ARIPO)||249||► subscribe|
|African Regional IP Organization (ARIPO)||9100253||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.